Marshall Wace’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.8M Sell
577,734
-165,721
-22% -$1.72M 0.01% 1327
2025
Q4
$9.19M Sell
743,455
-168,933
-19% -$1.81M 0.01% 909
2025
Q3
$8.05M Sell
912,388
-106,459
-10% -$828K 0.01% 1001
2025
Q2
$6.5M Sell
1,018,847
-139,015
-12% -$795K 0.01% 1025
2025
Q1
$5.63M Sell
1,157,862
-170,779
-13% -$1.41M 0.01% 1005
2024
Q4
$12.7M Sell
1,328,641
-1,165,943
-47% -$10.7M 0.02% 712
2024
Q3
$20.8M Buy
2,494,584
+1,951,771
+360% +$17.7M 0.03% 497
2024
Q2
$3.7M Buy
542,813
+233,341
+75% +$1M 0.01% 1123
2024
Q1
$783K Buy
309,472
+231,294
+296% +$521K ﹤0.01% 1752
2023
Q4
$188K Sell
78,178
-81,602
-51% -$192K ﹤0.01% 1989
2023
Q3
$543K Sell
159,780
-25,784
-14% -$143K ﹤0.01% 1696
2023
Q2
$1.36M Buy
185,564
+173,732
+1,468% +$1.61M ﹤0.01% 1598
2023
Q1
$123K Buy
+11,832
New +$143K ﹤0.01% 2483
2022
Q3
Sell
-448,533
Closed -$13.9M 3467
2022
Q2
$13.9M Buy
+448,533
New +$15.3M 0.03% 657
2022
Q1
Sell
-20,519
Closed -$893K 3524
2021
Q4
$893K Sell
20,519
-102,200
-83% -$4.62M ﹤0.01% 2530
2021
Q3
$6.14M Buy
122,719
+11,296
+10% +$684K 0.03% 824
2021
Q2
$7.02M Buy
+111,423
New +$7.16M 0.04% 653
2020
Q1
Sell
-163,975
Closed -$8.85M 1719
2019
Q4
$8.85M Sell
163,975
-130,267
-44% -$7.07M 0.07% 340
2019
Q3
$15.4M Buy
294,242
+218,936
+291% +$10.2M 0.13% 198
2019
Q2
$3.64M Buy
+75,306
New +$3.61M 0.03% 589
2015
Q3
Sell
-16,729
Closed -$551K 953
2015
Q2
$551K Buy
+16,729
New +$519K 0.01% 693
2014
Q4
Sell
-33,002
Closed -$703K 850
2014
Q3
$703K Sell
33,002
-109,648
-77% -$2.51M 0.01% 603
2014
Q2
$3.2M Buy
+142,650
New +$3.32M 0.05% 326

Other funds holding EBS